Treatment of pregnant BALB/c mice with sulphadoxine pyrimethamine or chloroquine abrogates Plasmodium berghei induced placental pathology

Parasitology International

Volumn 63, Issue 1, 2014, Pages 49-56

  Sharma, Lalita ^a   Shukla, Geeta ^a  

^a PANJAB UNIVERSITY   (India)

Author keywords

Catalase; Chloroquine; Malaria; Malondialdehyde; Placenta; Pregnancy; Sulphadoxine pyrimethamine; Superoxide dismutase

Indexed keywords

CHLOROQUINE; LIPID; MALONALDEHYDE; PYRIMETHAMINE PLUS SULFADOXINE; CATALASE; GLUTATHIONE; SUPEROXIDE DISMUTASE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; APOPTOSIS; ARTICLE; CELL STRUCTURE; CONTROLLED STUDY; DRUG EFFICACY; FEMALE; HISTOPATHOLOGY; LIPID PEROXIDATION; NONHUMAN; PARASITEMIA; PLACENTA DISORDER; PLASMODIUM BERGHEI INFECTION; PRIORITY JOURNAL; SECOND TRIMESTER PREGNANCY; SURVIVAL; TREATMENT OUTCOME; ENZYME ACTIVITY; ERYTHROCYTE STRUCTURE; FETUS DEVELOPMENT; HISTOLOGY; MOUSE; OXIDATIVE STRESS; SINGLE DRUG DOSE; SURVIVAL RATE;

MUS; PLASMODIUM BERGHEI;

CATALASE; CHLOROQUINE; MALARIA; MALONDIALDEHYDE; PLACENTA; PREGNANCY; SULPHADOXINE PYRIMETHAMINE; SUPEROXIDE DISMUTASE;

ANIMALS; ANTIMALARIALS; ANTIOXIDANTS; CHLOROQUINE; DNA FRAGMENTATION; DRUG COMBINATIONS; FEMALE; LIPID PEROXIDATION; MALARIA; MICE; MICE, INBRED BALB C; PARASITEMIA; PLACENTA DISEASES; PLASMODIUM BERGHEI; PREGNANCY; PREGNANCY COMPLICATIONS, PARASITIC; PYRIMETHAMINE; SULFADOXINE;

EID: 84888135655     PISSN: 13835769     EISSN: 18730329     Source Type: Journal    
DOI: 10.1016/j.parint.2013.08.016     Document Type: Article

References (36)

1. World Malaria Report 2011, World Health Organization, Geneva, Switzerland.
2. Desai M., Ter Kuile F.O., Nosten F., McGready R., Asamoa K., Brabin B. Epidemiology and burden of malaria in pregnancy. Lancet Infec Dis 2007, 7:93-104.
3. Brabin B.J., Wasame M., Uddenfeldt-Wort U., Dellicour S., Hill J., Gies S. Monitoring and evaluation of malaria in pregnancy - developing a rational basis for control. Malar. J. 2008, 7:S1-S6.
4. WHO UNICEF The Africa Malaria Report 2003, 1093. WHO/CDS/MAL/, World Health Organization, Geneva, Switzerland.
5. Steketee R.W., Nahlen B.L., Parise M.E., Menendez C. The burden of malaria in pregnancy in malaria-endemic areas. Am J Trop Med Hyg 2001, 64(S):28-35.
6. Saba N., Sultana A., Mahsud I. Outcome and complications of malaria in pregnancy. Gomal J Med Sci 2008, 6:98-101.
7. Chawla S.S., Manu S.V. Malaria in pregnancy. MJAFI 2007, 63:147-148.
8. Menendez C., Ordi J., Ismail M.R., Ventura P.J., Aponte J.J., Kahigwa E. The impact of placental malaria on gestational age and birth weight. J Infect Dis 2000, 181:1740-1750.
9. Neres R., Marinho C.R.F., Goncalves L.A., Catarino M.B., Penha-Goncalves C. Pregnancy outcome and placenta pathology in Plasmodium berghei ANKA infected mice reproduce the pathogenesis of severe malaria in pregnant women. PLoS One 2008, 3:e1608.
10. Poovassery J., Moore J.M. Murine malaria infection induces fetal loss associated with accumulation of Plasmodium chabaudi AS-Infected erythrocytes in the placenta. Infect Immun 2006, 74:2839-2848.
11. Rogerson S.J., Pollina E., Getachew A., Tadesse E., Lema V.M., Molyneux M.E. Placental monocyte infiltrates in response to Plasmodium falciparum malaria infection and their association with adverse pregnancy outcomes. Am J Trop Med Hyg 2003, 68:115-119.
12. Sharma L., Kaur J., Rishi P., Shukla G. Plasmodium berghei: influence of infection on the oxidant and antioxidants levels in pregnant BALB/c mice. Exp Parasitol 2012, 131:215-222.
13. Sharma L., Kaur J., Shukla G. Role of oxidative stress and apoptosis in the placental pathology of Plasmodium berghei infected mice. PLoS One 2012, 7:e32694.
14. Nosten F., McGready R., Verhoeff F., Menendez C., Ana Bonell A., d'Alessandro U. Antimalarial drugs in pregnancy: a review. Curr Drug Saf 2006, 1:1-15.
15. WHO/AFRO A Strategic Framework for Malaria Prevention and Control During Pregnancy in the African Region 2004, World Health Organization Regional Office for Africa.
16. NVBDCP Directorate of National Vector Borne Disease Control Programme (Directorate General of Health Services) Ministry of Health & Family Welfare, Delhi. Malaria Drug Policy 2007, NVBDCP, [http://www.nvbdcp.gov.in].
17. Ahmed A., Bararia D., Vinayak S., Yameen M., Biswas S., Dev V. Plasmodium falciparum isolates in India exhibit a progressive increase in mutations associated with sulfadoxine-pyrimethamine resistance. Antimicrob Agents Chemother 2004, 48:879-889.
18. Vinayak V.K., Pathak G., Asnani P.J., Jain S., Malik A.K. Influence of malaria infection on maternal foetal relationship in pregnant mice. Aust J Exp Biol Med Sci 1986, 64:223-227.
19. Peters W. The chemotherapy of rodent malaria. XXII. The value of drug resistance strains of Plasmodium berghei in screening for blood schizontocidal activity. Ann. Trop. Med Parasitol 1975, 69:155-171.
20. Uhegbu F.O., Igwe C.U., Oze G.O., Ojiako A.O. Comparative anti-malarial effects of sulphadoxine/pyrimethamine and aqueous leaf extract of Carica papaya, Magnifera indica in mice. Niger J Biochem Mol Boil 2009, 24:29-31.
21. Lowry O.H., Rosenbrough N.J., Farr A.L. Protein measurement with folin's phenol reagent. J Biol Chem 1951, 193:265-275.
22. Wills E.D. Mechanism of lipid peroxidation formation in animal tissues. Biochem J 1996, 99:667-676.
23. Catalase Luck H. Methods of Enzymatic Analysis 1971, 885-894. Academic press, New York. H.U. Bergmeyer (Ed.).
24. Ellman G.L. Tissue sulfhydryl groups. Arch Biochem 1959, 82:70-77.
25. Kono Y. Generation of superoxide radical during autooxidation of hydroxylamine and an assay of superoxide dismutase. Arch Biochem Biophys 1978, 186:189-195.
26. Strauss W.M. Preparation of genomic DNA from mammalian tissue. Current Protocols in Molecular Biology 1987, 221-223. Greene Publishing Associates & Wiley Interscience, New York. F.K. Ausubel, R. Brent, R.E. Kingston (Eds.).
27. Aregawi M., Cibulskis R., Otten M., Williams R., Dye C. World Malaria Report 2008, 1. [WHO/HTM/GMP/].
28. Kumar A., Valecha N., Jain T., Dash A.P. Burden of malaria in India: retrospective and prospective view. Am J Trop Med Hyg 2007, 77:69-78.
29. Mohd Ridzuan M.A.R., Ruenruetai U., Noor R.A., And Khozirah S., Zakiah I. Antimalarial properties of Goniothalamin in combination with chloroquine against Plasmodium yoelli and Plasmodium berghei growth in mice. Trop Biomed 2006, 23(2):140-146.
30. Chandel S., Bagai U. Antiplasmodial activity of Ajuga bracteosa against Plasmodium berghei infected BALB/C mice. Ind J Med Res 2010, 131:440-444.
31. Jauniaux E., Poston L., Burton G.J. Placental-related diseases of pregnancy: involvement of oxidative stress and implications in human evolution. Hum Reprod Update 2006, 12:747-755.
32. Hubel C.A. Oxidative Stress in the Pathogenesis of Preeclampsia 1999, 222. PSEBM.
33. Farombi E.O., Shyntum Y.Y., Emerole G.O. Influence of chloroquine treatment and Plasmodium falciparum malaria infection on some enzymatic and non-enzymatic antioxidant defense indices in humans. Drug Chem Toxicol 2003, 26:59-71.
34. Leke R.G.F., Taylor D.W. The use of intermittent preventive treatment with sulphadoxine- pyrimethamine for preventing malaria in pregnant women. Clin Infect Dis 2011, 53:231-233.
35. Rogerson S.J., Chaluluka E., Kanjala M., Mkundika P., Mhango C., Molyneux M.E. Intermittent sulfadoxine-pyrimethamine in pregnancy: effectiveness against malaria morbidity in Blantyre, Malawi, in 1997-99. Trans R Soc Trop Med Hyg 2000, 94:549-553.
36. Parise M.E., Ayisi J.G., Nahlen B.L., Schultz L.J., Roberts J.M., Misore A. Efficacy of sulfadoxine-pyrimethamine for prevention of placental malaria in an area of Kenya with a high prevalence of malaria and human immunodeficiency virus infection. Am J Trop Med Hyg 1998, 59:813-822.